Posted by Michael Wonder on 02 Feb 2020
Schedule of Pharmaceutical Benefits - 1 February 2020 update
1 February 2020 - The January 2020 issue of the Schedule of Pharmaceutical Benefits is out and now in effect.
The January issue of the Schedule includes a few new listings:
- Cinacalcet hydrochloride (Pharmacor Cinacalcet) - new formulation
- Lisdexamphetamine dimesylate (Vyvanse) - new strength
- Octreotide acetate (Sandostatin LAR) - new indication
- Tiotropium bromide monohydrate (Braltus) - new formulation
